Matches in Wikidata for { <http://www.wikidata.org/entity/Q62809161> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q62809161 description "clinical trial" @default.
- Q62809161 description "ensayu clínicu" @default.
- Q62809161 description "klinisch onderzoek" @default.
- Q62809161 description "клінічне випробування" @default.
- Q62809161 name "Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)" @default.
- Q62809161 type Item @default.
- Q62809161 label "Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)" @default.
- Q62809161 prefLabel "Safety, Tolerability, and Efficacy of the Human Cytomegalovirus Vaccine (V160) in Healthy Women 16 to 35 Years of Age (V160-002)" @default.
- Q62809161 P1132 Q62809161-30D7005F-559C-405F-8E2B-21D92463D8F7 @default.
- Q62809161 P1476 Q62809161-9F676AF3-646B-46EC-940F-B36A60D0B3F4 @default.
- Q62809161 P17 Q62809161-00C29706-114C-432A-8947-3A203433782A @default.
- Q62809161 P17 Q62809161-2A1F8E29-D09C-4859-BF3C-89FDF2535BD1 @default.
- Q62809161 P17 Q62809161-2D63733A-A65E-4F45-AB7B-89E31F0FBD41 @default.
- Q62809161 P17 Q62809161-C30A1BE5-B75E-425B-A4C7-7181DC67E52E @default.
- Q62809161 P17 Q62809161-DC5A5D36-9396-4415-A7E3-AE94DF8087EA @default.
- Q62809161 P2899 Q62809161-19731EC6-BEFE-411E-966B-29CC01223BBC @default.
- Q62809161 P3098 Q62809161-904F358D-21DD-473E-826E-E2F5E1A0F946 @default.
- Q62809161 P31 Q62809161-13A11B9E-D3B0-4329-934C-EE7C61D59520 @default.
- Q62809161 P4135 Q62809161-F861B29B-A8B1-4960-ADD6-C70A332DAF6D @default.
- Q62809161 P580 Q62809161-BAD5C4D7-F396-4EDD-A8C9-FFA3BB3B375B @default.
- Q62809161 P582 Q62809161-63AEA1BC-85E1-4658-9515-FDB4257B9311 @default.
- Q62809161 P6099 Q62809161-D6093A9B-C6EE-4F65-977D-01A2AE927168 @default.
- Q62809161 P8363 Q62809161-4E3E012F-2A5E-450C-BCC0-3196517AF378 @default.
- Q62809161 P859 Q62809161-293CA239-0C80-437C-9C92-8B141663F6BF @default.
- Q62809161 P1132 "+2100" @default.
- Q62809161 P1476 "Double-Blind, Randomized, Placebo-Controlled Phase 2b, Multi-center Study to Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of a 2-Dose and a 3- Dose Regimen of V160 (Cytomegalovirus [CMV] Vaccine) in Healthy Seronegative Women, 16 to 35 Years of Age" @default.
- Q62809161 P17 Q16 @default.
- Q62809161 P17 Q29 @default.
- Q62809161 P17 Q30 @default.
- Q62809161 P17 Q33 @default.
- Q62809161 P17 Q801 @default.
- Q62809161 P2899 "+16" @default.
- Q62809161 P3098 "NCT03486834" @default.
- Q62809161 P31 Q30612 @default.
- Q62809161 P4135 "+35" @default.
- Q62809161 P580 "2018-04-30T00:00:00Z" @default.
- Q62809161 P582 "2021-05-14T00:00:00Z" @default.
- Q62809161 P6099 Q42824440 @default.
- Q62809161 P8363 Q78089383 @default.
- Q62809161 P859 Q58219685 @default.